Autologous Chondrocyte Implantation

Autologous Chondrocyte Implantation

Currently, autologous chondrocyte implantation  (ACI)  is  ideally  indicated  for  symptomatic  ICRS grade  III–IV  lesions  greater  than  2  cm 2 along  the  femoral  condyle  or  trochlear  regions.  High-demand patients  between  the  ages  of  15  to  55  years  of  age  with  excellent  motivation  and  compliance  potential should  be  chosen.

Read more

  • The American Board of Orthopaedic Surgery Website
  • The American Orthopaedic Society for Sports Medicine Website